Levi Miller, DO
Physical Medicine & Rehabilitation · Aurora, CONPI 1770713661
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 30.5% of the total.
Across 125 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$779
- Saluda Medical Americas, Inc.$213
- Pfizer$213
- Scilex Pharmaceuticals Inc.$194
- SPR Therapeutics, Inc$140
- Biohaven Pharmaceuticals, Inc.$100
- plus $919 from 26 others
What the payments were for
- Food & beverage$2,559100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $779 |
| Saluda Medical Americas, Inc. | 6 | $213 |
| Pfizer | 11 | $213 |
| Scilex Pharmaceuticals Inc. | 13 | $194 |
| SPR Therapeutics, Inc | 6 | $140 |
| Biohaven Pharmaceuticals, Inc. | 5 | $100 |
| Abbott | 3 | $97 |
| Collegium Pharmaceutical, Inc. | 5 | $95 |
| Boston Scientific | 3 | $94 |
| Novartis | 5 | $84 |
| Lilly USA, LLC | 4 | $56 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Eisai Inc. | 2 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Nalu Medical, Inc. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| AstraZeneca | 2 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Painteq LLC | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Curonix LLC | 1 | $14 |
| Kaleo, Inc. | 1 | $13 |
| Stimwave Technologies Incorporated | 1 | $11 |
How this compares
$2,559 in reported general payments places this provider in the 85th percentile of 199 physical medicine & rehabilitation providers in Colorado.
See all physical medicine & rehabilitation providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 35 | $19,178 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 95 | $3,515 |
| Oxycodone Hcl | 138 | $3,363 |
| Morphine Sulfate ErMorphine Sulfate | 72 | $2,015 |
| Doxepin Hcl | 15 | $1,717 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $1,671 |
| Fentanyl | 16 | $1,402 |
| Tizanidine Hcl | 23 | $665 |
| Dextroamphetamine Sulfate | 11 | $627 |
| Gabapentin | 41 | $608 |
| Methadone Hcl | 16 | $606 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 19 | $547 |
| Methocarbamol | 14 | $343 |
| Pregabalin | 13 | $294 |
| Cyclobenzaprine Hcl | 17 | $233 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $95 | $19,17835 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 199 physical medicine & rehabilitation providers in Colorado.
Other physical medicine & rehabilitation in Aurora
- Barry OginAurora$6K
- Steven SianoAurora$4K
- David ReinhardAurora$3K
- Gretchen BrunworthAurora$3K
- Franchesca KonigAurora$2K
- Dustin AndersonAurora$1K
- Amit SinhaAurora$1K
- Lawrence LesnakAurora$937
- Austin BoosAurora$903
- Venu AkuthotaAurora$832
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.